• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[病理肿瘤体积预测局部晚期声门癌患者的生存结局]

[Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].

作者信息

Gong Hongli, Zhou Liang, Tao Lei, Zhang Ming, Wu Haitao, Chen Xiaoling, Li Xiaoming, Li Cai, Zhou Jian

机构信息

Department of Otolaryngology Head and Neck Surgery,Eye & ENT Hospital of Fudan University,Shanghai,200031,China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):316-320. doi: 10.13201/j.issn.2096-7993.2021.04.007.

DOI:10.13201/j.issn.2096-7993.2021.04.007
PMID:33794628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10128446/
Abstract

The aim of this study was to evaluate the predicting role of tumor volume as evaluated by postoperative pathologic examination on overall survival(OS) and disease free survival(DFS) in patients with local advanced glottic carcinoma. In this study, the records of 406 consecutive patients with local advanced glottic carcinoma(T3-T4 stages) who underwent surgery ± chemoradiotherapy from January 2005 to December 2010 were retrospectively reviewed and followed up. The demographic characteristics, disease staging, and pathologic tumor volume were analyzed. The optimal cutoff values of tumor volume for OS and DFS were obtained by using receiver operating characteristic(ROC) curves. The association of tumor volume with T stages were assessed by using Logistic regression model, and the relationship between tumor volume and OS and DFS rates were evaluated by using Cox regression models. The 5-and 10-year OS rates were 62.9% and 55.4%, respectively. The 5-and 10-year DFS rates were 55.5% and 50.8%, respectively. The mean tumor volume was(5.1±6.7) cm³, T4 stage patients had higher tumor volume than those of patients with T3 stage(<0.001). The factor of tumor volume was correlated with T stages by using Logistic regression analyses(=13.81, 95%: 6.03-31.59, <0.001). The optimal cutoff values of tumor volume that were both at 3 cm³ for OS and DFS rates were obtained by using ROC curve plots. The OS and DFS rates of glottic carcinoma patients with tumor volume ≤ 3 cm³ were better when compared with those of patients with tumor volume>3 cm³(<0.001). Upon multivariate analyses, tumor volume was strongly correlated with poorer OS and DFS rates and remained independent prognostic factors for both the OS and DFS of patients with glottic carcinoma(OS: =1.59, 95%: 1.09-2.32, =0.017; DFS: =1.54, 95%: 1.08-2.20, =0.016). This study demonstrates that tumor volume is correlated with T stages, and this factor is an independent predictive factor of survival outcomes in patients with local advanced glottic carcinoma.

摘要

本研究旨在评估术后病理检查所评估的肿瘤体积对局部晚期声门癌患者总生存期(OS)和无病生存期(DFS)的预测作用。在本研究中,回顾性分析并随访了2005年1月至2010年12月期间连续406例行手术±放化疗的局部晚期声门癌(T3 - T4期)患者的记录。分析了患者的人口统计学特征、疾病分期和病理肿瘤体积。通过绘制受试者工作特征(ROC)曲线得出OS和DFS的肿瘤体积最佳截断值。采用Logistic回归模型评估肿瘤体积与T分期的相关性,采用Cox回归模型评估肿瘤体积与OS及DFS率之间的关系。5年和10年OS率分别为62.9%和55.4%。5年和10年DFS率分别为55.5%和50.8%。平均肿瘤体积为(5.1±6.7)cm³,T4期患者的肿瘤体积高于T3期患者(<0.001)。通过Logistic回归分析,肿瘤体积因素与T分期相关(=13.81,95%置信区间:6.03 - 31.59,<0.001)。通过ROC曲线绘制得出OS和DFS率的肿瘤体积最佳截断值均为3 cm³。肿瘤体积≤3 cm³的声门癌患者的OS和DFS率优于肿瘤体积>3 cm³的患者(<0.001)。多因素分析显示,肿瘤体积与较差的OS和DFS率密切相关,并且仍然是声门癌患者OS和DFS的独立预后因素(OS:=1.59,95%置信区间:1.09 - 2.32,=0.017;DFS:=1.54,95%置信区间:1.08 - 2.20,=0.016)。本研究表明,肿瘤体积与T分期相关,并且该因素是局部晚期声门癌患者生存结局的独立预测因素。

相似文献

1
[Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].[病理肿瘤体积预测局部晚期声门癌患者的生存结局]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Apr;35(4):316-320. doi: 10.13201/j.issn.2096-7993.2021.04.007.
2
Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.肿瘤大小与声门型喉癌患者生存结局的相关性研究
Otolaryngol Head Neck Surg. 2021 Feb;164(2):353-358. doi: 10.1177/0194599820937296. Epub 2020 Jul 7.
3
Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.声门上型和声带型喉癌中肿瘤体积的重要性。
Strahlenther Onkol. 2013 Dec;189(12):1009-14. doi: 10.1007/s00066-013-0467-2. Epub 2013 Nov 8.
4
Preoperative tracheotomy as reflection of tumor size impacting oncologic outcomes of patients with advanced stage glottic carcinoma.术前气管切开术反映肿瘤大小对晚期声门型喉癌患者肿瘤学结局的影响。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4943-4950. doi: 10.1007/s00405-021-06721-9. Epub 2021 Mar 6.
5
Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.T2期声门型喉鳞状细胞癌患者病理癌灶大小的预测价值
Acta Otolaryngol. 2023 Apr;143(4):317-321. doi: 10.1080/00016489.2023.2188083. Epub 2023 Mar 30.
6
Prognostic value of pathological tumor size in patients with supraglottic carcinoma.声门上型癌患者病理肿瘤大小的预后价值。
Am J Otolaryngol. 2021 Jan-Feb;42(1):102757. doi: 10.1016/j.amjoto.2020.102757. Epub 2020 Oct 19.
7
Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research Initiative.加拿大头颈部合作研究倡议:研究放疗治疗 T3 声门型喉癌患者原发肿瘤体积与生存的关系。
JAMA Otolaryngol Head Neck Surg. 2023 Feb 1;149(2):103-109. doi: 10.1001/jamaoto.2022.3996.
8
Low expression of pRB predicts disease relapse in early glottic cancer treated with transoral laser microsurgery.pRB低表达预示经口激光显微手术治疗的早期声门癌疾病复发。
Laryngoscope. 2019 Jun;129(6):E220-E226. doi: 10.1002/lary.27612. Epub 2018 Nov 1.
9
Tumor volume as a prognostic factor of locally advanced laryngeal cancer.肿瘤体积作为局部晚期喉癌的预后因素。
Eur Arch Otorhinolaryngol. 2021 May;278(5):1627-1635. doi: 10.1007/s00405-020-06438-1. Epub 2020 Oct 23.
10
Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.经口激光显微手术治疗声门癌中病理确定的肿瘤体积的预后意义
Clin Otolaryngol. 2015 Dec;40(6):610-5. doi: 10.1111/coa.12421.

引用本文的文献

1
[Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].[预测喉鳞状细胞癌患者术后预后的列线图的开发与验证]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec;36(12):902-909. doi: 10.13201/j.issn.2096-7993.2022.12.003.

本文引用的文献

1
[Progress in CT and MRI of preoperative T staging of laryngeal carcinoma].[喉癌术前T分期的CT与MRI研究进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 May;34(5):470-474. doi: 10.13201/j.issn.2096-7993.2020.05.022.
2
[The progress on diagnosis and treatment of larynx cancer].[喉癌的诊断与治疗进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Nov;33(11):1017-1021. doi: 10.13201/j.issn.1001-1781.2019.11.003.
3
[Treatment options for advanced laryngeal carcinoma].[晚期喉癌的治疗选择]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):398-400. doi: 10.3760/cma.j.issn.1673-0860.2019.05.018.
4
Incidence and mortality of laryngeal cancer in China, 2008-2012.2008 - 2012年中国喉癌的发病率和死亡率
Chin J Cancer Res. 2018 Jun;30(3):299-306. doi: 10.21147/j.issn.1000-9604.2018.03.02.
5
[Significance of induction chemotherapy in the treatment of locally advanced laryngeal cancer and hypopharyngeal cancer].[诱导化疗在局部晚期喉癌和下咽癌治疗中的意义]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Oct 5;30(19):1548-1551. doi: 10.13201/j.issn.1001-1781.2016.19.011.
6
Tumor volume as a predictor of survival in T3 glottic carcinoma: A novel approach to patient selection.肿瘤体积作为 T3 声门型喉癌患者生存预测因素的研究:一种新的患者选择方法。
Oral Oncol. 2018 Apr;79:47-54. doi: 10.1016/j.oraloncology.2018.02.015. Epub 2018 Feb 22.
7
Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.定量术前CT容积测量:与T4a期喉鳞状细胞癌患者肿瘤学结局的相关性
Head Neck. 2017 Aug;39(8):1609-1620. doi: 10.1002/hed.24804. Epub 2017 May 2.
8
Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.采用手术多模式方案治疗的局部区域晚期喉癌患者的预测和预后因素。
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1701-1711. doi: 10.1007/s00405-016-4411-9. Epub 2016 Dec 10.
9
Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.晚期喉癌的治疗与生存趋势:荷兰一项基于人群的20年研究。
Head Neck. 2016 Apr;38 Suppl 1:E1247-55. doi: 10.1002/hed.24200. Epub 2015 Aug 28.
10
Survival outcomes in advanced laryngeal cancer.晚期喉癌的生存结果。
JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):855-60. doi: 10.1001/jamaoto.2014.1671.